Mohammed Ibn-Mas'ud Danjuma

26PUBLICATIONS
38CO-AUTHORS
PharmacogenomicsHaematological tumoursRespiratory diseasesNaturopathyPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (26)

|Apr 02, 2026
Prevalence and determinants of polypharmacy among cancer patients: a systematic review and meta-analysis.

Mohamed M Tawengi, Jawaher Baraka, Rafal Al Shibly

|Feb 27, 2026
Comparative Risks of Pneumonitis Amongst Immune Checkpoint Inhibitors in Patients with Lung Cancer: A Network Meta-Analysis of Randomized Clinical Trials.

Ruba Abdel Razzaq Ebzee, Ibrahim Yusuf Abubeker, Ahmed Aboughalia

|Feb 27, 2026
Therapeutic Drug Monitoring of Direct Oral Anticoagulants and Its Association with Clinical Outcomes: A Systematic Review and Meta-Analysis.

Layaly Bakir, Ibrahim Mohamed, Sharoma Yesukumar

|Jun 09, 2025
Direct Oral Anticoagulants Compared to Warfarin in Patients with Intermediate- to High-Risk Pulmonary Embolism: A Systematic Review and Meta-Analysis.

Mohamed Nabil Elshafei, Muhammad Salem, Mutasem Almistarihi

|Jun 07, 2024
Pharmacokinetics of single-dose rivaroxaban under fed state in obese vs. non-obese subjects: An open-label controlled clinical trial (RIVOBESE-PK).

Majdoleen Alalawneh, Ahmed Awaisu, Ibtihal Abdallah

|Oct 10, 2023
Trends in prescribing and outcomes in obese versus non-obese patients receiving rivaroxaban therapy: an observational study using real-world data.

Majdoleen Alalawneh, Ousama Rachid, Ibtihal Abdallah

Pageof 5

Frequent Collaborators

3 joint publications

Lina Mohammad Naseralallah

2 joint publications

Ibtihal Abdallah

2 joint publications

Ahmed Awaisu

2 joint publications

Hazem Elewa